Essex, United Kingdom

Michael G Russell

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: C4x Discovery Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael G Russell. Retrieved from https://idiyas.com/inventor/michael-g-russell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael G Russell: Innovator in Therapeutic Compounds

Introduction

Michael G Russell is a notable inventor based in Essex, GB. He has made significant contributions to the field of therapeutic compounds, particularly as an Nrf2 activator. His work focuses on the development of compounds that can potentially treat various diseases associated with Nrf2 activation.

Latest Patents

Michael G Russell holds 1 patent related to therapeutic compounds. This patent details compounds that act as Nrf2 activators, which are crucial for the treatment of diseases or disorders linked to Nrf2 activation. The structural formula of these compounds is defined within the patent, along with processes for their preparation and pharmaceutical compositions that include them.

Career Highlights

Michael is currently associated with C4X Discovery Limited, where he continues to innovate in the field of drug discovery and development. His expertise in therapeutic compounds has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Michael has collaborated with notable colleagues, including Emma Louise Blaney and Duncan J Crick. Their combined efforts contribute to advancing research and development in therapeutic applications.

Conclusion

Michael G Russell's work in therapeutic compounds exemplifies the impact of innovation in medicine. His contributions to Nrf2 activation research are paving the way for new treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…